Thursday, May 12th, 2016

About Non-Alcoholic Steatohepatitis (NASH)

NAFL disease, also known as fatty infiltration, is characterized by the accumulation of fat in the liver. It is of two types: NAFL and NASH. Fatty inflammation characterized by higher fat deposition than the normal level, 5%-10%, causes the disease. NASH causes severe inflammation of the liver, leading to damage of the organ. It is a benign condition of unknown etiology and is asymptomatic in nature during its initial stages, resulting in late diagnosis. Conditions such as obesity, diabetes, hyperlipidemia, insulin resistance, and toxicity by drugs such as amiodarone, tamoxifen, and perhexiline maleate can cause NASH. 

Technavio’s analysts forecast the global NASH market to grow at a CAGR of 24.58% during the period 2016-2020.

Complete report details @  


Covered in this report 
The report covers the present scenario and the growth prospects of the global NASH market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of off-label drugs, originally indicated for the treatment of diabetes, obesity, and associated conditions.

The market is divided into the following segments based on geography: 
• Americas 

Technavio's report, Global NASH Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors 
• Arena Pharmaceuticals 
• AstraZeneca 
• F Hoffmann-La Roche 
• GSK 
• Novo Nordisk 
• Vivus

Request a sample report @            


Other prominent vendors 
• Arisaph Pharmaceuticals 
• Cempra Pharmaceuticals 
• Galectin Therapeutics 
• Galmed Pharmaceuticals 
• Genfit 
• Gilead 
• Immuron 
• Interceptpharma 
• Raptor Pharmaceutical 
• Shire 
• Tobira Therapeutics 
• Verva 
• Viking Therapeutics

Market driver 
• Increase in sedentary lifestyle 
• For a full, detailed list, view our report

Market challenge 
• Limited understanding of disease pathophysiology 
• For a full, detailed list, view our report

Market trend 
• Patient assistance programs 
• For a full, detailed list, view our report

Key questions answered in this report 
• What will the market size be in 2020 and what will the growth rate be? 
• What are the key market trends? 
• What is driving this market? 
• What are the challenges to market growth? 
• Who are the key vendors in this market space? 
• What are the market opportunities and threats faced by the key vendors? 
• What are the strengths and weaknesses of the key vendors?

Make an enquiry before buying this Report @

Table of content

PART 01: Executive summary 
• Highlights 
PART 02: Scope of the report 
• Market overview 
• Top-vendor offerings 
PART 03: Market research methodology 
• Research methodology 
• Economic indicators 
PART 04: Introduction 
• Key market highlights 
PART 05: Disease overview 
• Understanding the disease 
• Symptoms and signs 
• Pathophysiology 
• Risk factors 
• Diagnosis 
• Treatment 
• Epidemiology 
• Economic burden 
PART 06: Pipeline analysis 
• Pipeline information of NASH 
• Clinical trials for NASH 
PART 07: Market landscape 
• Market overview 
• Market size and forecast 
• Five forces analysis 
PART 08: Market segmentation by dosage form 
• Solid 
• Liquid 
PART 09: Market segmentation by route of administration 
• Oral 
• Parenteral 
PART 10: Geographical segmentation 
• Global NASH drugs market by geographical segmentation 2015-2020 
• NASH drugs market in Americas 
• NASH drugs market in US 
• NASH drugs market in EMEA 
• NASH drugs market in APAC 
PART 11: Market drivers 
• Increase in sedentary lifestyle 
• Prevalence of associated health conditions 
• Promising pipeline 
• Significant unmet medical needs 
PART 12: Impact of drivers 
PART 13: Market challenges 

• Limited understanding of disease pathophysiology 
• Insufficient diagnostic technology for NASH 
• Stringent regulatory procedure 
• Adverse effects of drugs 
PART 14: Impact of drivers and challenges 
PART 15: Market trends 

• Rise in public awareness 
• Increase in strategic alliances 
• Patient assistance programs 
• Usage of off-label drugs 
PART 16: Vendor landscape 
• Competitive scenario 
• Arena Pharmaceuticals 
• AstraZeneca 
• F Hoffmann-La Roche 
• GSK 
• Novo Nordisk 
• Vivus 
• Other prominent vendors 
PART 17: Appendix 
• List of abbreviations 
PART 18: Explore Technavio 

Buy this report @


Contact US:


Partner Relations & Marketing Manager

[email protected]

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)          



File Library

Contact Profile


Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.

Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. We also provide COTS (Commercial off the Shelf) business sector reports as custom exploration agreeing your particular needs.

Our Market Research Reports and Consulting Services 

Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories. The Wise Guy Reports team prides itself in being the chosen source for market research reports, report customizations services, and other ancillary services such as a Newsletter service and corporate service for large organizations.

Hundreds of large and small organizations across virtually every industry sector worldwide are currently reaping rich dividends from the sharp insights provided by market research reports sourced through Wise Guy Reports. 

Gaining an insight into emerging trends, opportunities and potential threats is key to long-term sustenance in a competitive environment. The handpicked collection of market research reports on Wise Guy Reports is centred on this proven principle.

Norah Trent
P: +44 208 133 9349
M: +1 646 845 9349


Non-alcoholic Steatohepatitis market trend, Non-alcoholic Steatohepatitis market segmentation, Non-alcoholic Steatohepatitis market analysis, Non-alcoholic Steatohepatitis market parameters, Non-alcoholic Steatohepatitis industry forecast, Non-alcoho




More Formats

View QR Code